Clinical Trials Browser

Completed × cabozantinib × Other hematologic neoplasm × Clear all

NCT01961765 2017-07-21

Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute